{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:02:45Z","timestamp":1791406965767,"version":"4.3.3"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Koeln Fortune Program\/Faculty of Medicine, University of Cologne","award":["472\/2020"],"award-info":[{"award-number":["472\/2020"]}]},{"name":"Koeln Fortune Program\/Faculty of Medicine, University of Cologne","award":["472\/2020"],"award-info":[{"award-number":["472\/2020"]}]},{"DOI":"10.13039\/501100012681","name":"Universit\u00e4tsklinikum K\u00f6ln","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012681","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Autoimmune neuropathies can result in long-term disability and incomplete recovery, despite adequate first-line therapy. Kinesin-5 inhibition was shown to accelerate neurite outgrowth in different preclinical studies. Here, we evaluated the potential neuro-regenerative effects of the small molecule kinesin-5 inhibitor monastrol in a rodent model of acute autoimmune neuropathies, experimental autoimmune neuritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Experimental autoimmune neuritis was induced in Lewis rats with the neurogenic P2-peptide. At the beginning of the recovery phase at day 18, the animals were treated with 1\u00a0mg\/kg monastrol or sham and observed until day 30 post-immunisation. Electrophysiological and histological analysis for markers of inflammation and remyelination of the sciatic nerve were performed. Neuromuscular junctions of the tibialis anterior muscles were analysed for reinnervation. We further treated human induced pluripotent stem cells-derived secondary motor neurons with monastrol in different concentrations and performed a neurite outgrowth assay.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Treatment with monastrol enhanced functional and histological recovery in experimental autoimmune neuritis. Motor nerve conduction velocity at day 30 in the treated animals was comparable to pre-neuritis values. Monastrol-treated animals showed partially reinnervated or intact neuromuscular junctions. A significant and dose-dependent accelerated neurite outgrowth was observed after kinesin-5 inhibition as a possible mode of action.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pharmacological kinesin-5 inhibition improves the functional outcome in experimental autoimmune neuritis through accelerated motor neurite outgrowth and histological recovery. This approach could be of interest to improve the outcome of autoimmune neuropathy patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12974-023-02822-w","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T16:01:37Z","timestamp":1686326497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Kinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis"],"prefix":"10.1186","volume":"20","author":[{"given":"Felix","family":"Kohle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Ackfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Hommen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K. R.","family":"Sva\u010dina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gereon R.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Barham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vilchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmar C.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"2822_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s42466-020-00064-2","volume":"2","author":"HC Lehmann","year":"2020","unstructured":"Lehmann HC, Wunderlich G, Fink GR, Sommer C. Diagnosis of peripheral neuropathy. Neurol Res Pract. 2020;2:20.","journal-title":"Neurol Res Pract"},{"key":"2822_CR2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","volume":"397","author":"N Shahrizaila","year":"2021","unstructured":"Shahrizaila N, Lehmann HC, Kuwabara S. Guillain\u2013Barr\u00e9 syndrome. Lancet. 2021;397:1214\u201328.","journal-title":"Lancet"},{"key":"2822_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/16501970600582997","volume":"38","author":"A Forsberg","year":"2006","unstructured":"Forsberg A, de Pedro-Cuesta J, Wid\u00e9n Holmqvist L. Use of healthcare, patient satisfaction and burden of care in Guillain-Barre syndrome. J Rehabil Med. 2006;38:230\u20136.","journal-title":"J Rehabil Med"},{"key":"2822_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1756285609104792","volume":"2","author":"HC Lehmann","year":"2009","unstructured":"Lehmann HC, Meyer Horste G, Kieseier BC, Hartung HP. Pathogenesis and treatment of immune-mediated neuropathies. Ther Adv Neurol Disord. 2009;2:261\u201381.","journal-title":"Ther Adv Neurol Disord"},{"key":"2822_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1357-4310(99)01639-1","volume":"6","author":"R Gold","year":"2000","unstructured":"Gold R, Hartung HP, Toyka KV. Animal models for autoimmune demyelinating disorders of the nervous system. Mol Med Today. 2000;6:88\u201391.","journal-title":"Mol Med Today"},{"key":"2822_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12974-020-01737-0","volume":"17","author":"P Altmann","year":"2020","unstructured":"Altmann P, De Simoni D, Kaider A, Ludwig B, Rath J, Leutmezer F, Zimprich F, Hoeftberger R, Lunn MP, Heslegrave A, et al. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain\u2013Barr\u00e9 syndrome. J Neuroinflammation. 2020;17:86.","journal-title":"J Neuroinflammation"},{"key":"2822_CR7","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1111\/ene.14476","volume":"27","author":"T Gr\u00fcter","year":"2020","unstructured":"Gr\u00fcter T, Motte J, Fisse AL, Bulut Y, K\u00f6se N, Athanasopoulos D, Otto S, Yoon MS, Schneider-Gold C, Gold R, Pitarokoili K. Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy. Eur J Neurol. 2020;27:2595\u2013603.","journal-title":"Eur J Neurol"},{"key":"2822_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.expneurol.2009.12.033","volume":"223","author":"JW Griffin","year":"2010","unstructured":"Griffin JW, Pan B, Polley MA, Hoffman PN, Farah MH. Measuring nerve regeneration in the mouse. Exp Neurol. 2010;223:60\u201371.","journal-title":"Exp Neurol"},{"key":"2822_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1749-8104-8-17","volume":"8","author":"A Prokop","year":"2013","unstructured":"Prokop A. The intricate relationship between microtubules and their associated motor proteins during axon growth and maintenance. Neural Dev. 2013;8:17\u201317.","journal-title":"Neural Dev"},{"key":"2822_CR10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.cub.2019.12.056","volume":"30","author":"Y Cao","year":"2020","unstructured":"Cao Y, Lipka J, Stucchi R, Burute M, Pan X, Portegies S, Tas R, Willems J, Will L, MacGillavry H, et al. Microtubule minus-end binding protein CAMSAP2 and kinesin-14 motor KIFC3 control dendritic microtubule organization. Curr Biol. 2020;30:899-908.e896.","journal-title":"Curr Biol"},{"key":"2822_CR11","doi-asserted-by":"publisher","first-page":"845","DOI":"10.4103\/1673-5374.158351","volume":"10","author":"PW Baas","year":"2015","unstructured":"Baas PW, Matamoros AJ. Inhibition of kinesin-5 improves regeneration of injured axons by a novel microtubule-based mechanism. Neural Regen Res. 2015;10:845\u20139.","journal-title":"Neural Regen Res"},{"key":"2822_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/toxics9100229","volume":"9","author":"I Klein","year":"2021","unstructured":"Klein I, Lehmann HC. Pathomechanisms of paclitaxel-induced peripheral neuropathy. Toxics. 2021;9:229.","journal-title":"Toxics."},{"key":"2822_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1600-0854.2010.01152.x","volume":"12","author":"S Lin","year":"2011","unstructured":"Lin S, Liu M, Son YJ, Timothy Himes B, Snow DM, Yu W, Baas PW. Inhibition of Kinesin-5, a microtubule-based motor protein, as a strategy for enhancing regeneration of adult axons. Traffic. 2011;12:269\u201386.","journal-title":"Traffic"},{"key":"2822_CR14","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1083\/jcb.200702074","volume":"178","author":"KA Myers","year":"2007","unstructured":"Myers KA, Baas PW. Kinesin-5 regulates the growth of the axon by acting as a brake on its microtubule array. J Cell Biol. 2007;178:1081\u201391.","journal-title":"J Cell Biol"},{"key":"2822_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2014.10.013","volume":"263","author":"C Xu","year":"2015","unstructured":"Xu C, Klaw MC, Lemay MA, Baas PW, Tom VJ. Pharmacologically inhibiting kinesin-5 activity with monastrol promotes axonal regeneration following spinal cord injury. Exp Neurol. 2015;263:172\u20136.","journal-title":"Exp Neurol"},{"key":"2822_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01263-2","author":"N Wei","year":"2022","unstructured":"Wei N, Yu Y, Yang Y, Wang X-L, Zhong Z-J, Chen X-F, Yu Y-Q. Inhibitions and down-regulation of motor protein Eg5 expression in primary sensory neurons reveal a novel therapeutic target for pathological pain. Neurotherapeutics. 2022. https:\/\/doi.org\/10.1007\/s13311-022-01263-2.","journal-title":"Neurotherapeutics"},{"key":"2822_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s12640-017-9760-7","volume":"32","author":"I Bobylev","year":"2017","unstructured":"Bobylev I, Peters D, Vyas M, Barham M, Klein I, von Strandmann EP, Neiss WF, Lehmann HC. Kinesin-5 blocker monastrol protects against bortezomib-induced peripheral neurotoxicity. Neurotox Res. 2017;32:555\u201362.","journal-title":"Neurotox Res"},{"key":"2822_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/bi026716j","volume":"42","author":"S DeBonis","year":"2003","unstructured":"DeBonis S, Simorre JP, Crevel I, Lebeau L, Skoufias DA, Blangy A, Ebel C, Gans P, Cross R, Hackney DD, et al. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5. Biochemistry. 2003;42:338\u201349.","journal-title":"Biochemistry"},{"key":"2822_CR19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.286.5441.971","volume":"286","author":"TU Mayer","year":"1999","unstructured":"Mayer TU, Kapoor TM, Haggarty SJ, King RW, Schreiber SL, Mitchison TJ. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science. 1999;286:971\u20134.","journal-title":"Science"},{"issue":"Pt 7","key":"2822_CR20","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/brain\/121.7.1257","volume":"121","author":"U Enders","year":"1998","unstructured":"Enders U, Lobb R, Pepinsky RB, Hartung HP, Toyka KV, Gold R. The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the Lewis rat. Brain. 1998;121(Pt 7):1257\u201366.","journal-title":"Brain"},{"key":"2822_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-4886(85)90129-3","volume":"87","author":"RH King","year":"1985","unstructured":"King RH, Craggs RI, Gross ML, Thomas PK. Effects of glucocorticoids on experimental allergic neuritis. Exp Neurol. 1985;87:9\u201319.","journal-title":"Exp Neurol"},{"key":"2822_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577470","volume":"352","author":"F Kohle","year":"2021","unstructured":"Kohle F, Sprenger A, Klein I, Fink GR, Lehmann HC. Nerve conductions studies in experimental models of autoimmune neuritis: a meta-analysis and guideline. J Neuroimmunol. 2021;352: 577470.","journal-title":"J Neuroimmunol"},{"key":"2822_CR23","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3465","volume":"9","author":"AR Crowe","year":"2019","unstructured":"Crowe AR, Yue W. Semi-quantitative determination of protein expression using immunohistochemistry staining and analysis: an integrated protocol. Bio-Protoc. 2019;9: e3465.","journal-title":"Bio-Protoc"},{"key":"2822_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jneuroim.2017.05.008","volume":"309","author":"K Pitarokoili","year":"2017","unstructured":"Pitarokoili K, Kohle F, Motte J, Fatoba O, Pedreiturria X, Gold R, Yoon MS. Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis. J Neuroimmunol. 2017;309:58\u201367.","journal-title":"J Neuroimmunol"},{"key":"2822_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007754","volume":"4","author":"T Chomiak","year":"2009","unstructured":"Chomiak T, Hu B. What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach. PLoS ONE. 2009;4: e7754.","journal-title":"PLoS ONE"},{"key":"2822_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1113\/expphysiol.1982.sp002663","volume":"67","author":"TJ Biscoe","year":"1982","unstructured":"Biscoe TJ, Nickels SM, Stirling CA. Numbers and sizes of nerve fibres in mouse spinal roots. Q J Exp Physiol. 1982;67:473\u201394.","journal-title":"Q J Exp Physiol"},{"key":"2822_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jneumeth.2014.02.005","volume":"227","author":"JN Sleigh","year":"2014","unstructured":"Sleigh JN, Burgess RW, Gillingwater TH, Cader MZ. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles. J Neurosci Methods. 2014;227:159\u201365.","journal-title":"J Neurosci Methods"},{"key":"2822_CR28","doi-asserted-by":"publisher","first-page":"E7701","DOI":"10.1073\/pnas.1611673113","volume":"113","author":"SJ Hill","year":"2016","unstructured":"Hill SJ, Mordes DA, Cameron LA, Neuberg DS, Landini S, Eggan K, Livingston DM. Two familial ALS proteins function in prevention\/repair of transcription-associated DNA damage. Proc Natl Acad Sci. 2016;113:E7701\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"2822_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/cyto.a.20022","volume":"58A","author":"E Meijering","year":"2004","unstructured":"Meijering E, Jacob M, Sarria J-CF, Steiner P, Hirling H, Unser M. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytom Part A. 2004;58A:167\u201376.","journal-title":"Cytom Part A."},{"key":"2822_CR30","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1113\/jphysiol.2009.171702","volume":"587","author":"JJ Plomp","year":"2009","unstructured":"Plomp JJ, Willison HJ. Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction. J Physiol. 2009;587:3979\u201399.","journal-title":"J Physiol"},{"key":"2822_CR31","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/brain\/awh231","volume":"127","author":"SK Halstead","year":"2004","unstructured":"Halstead SK, O\u2019Hanlon GM, Humphreys PD, Morrison DB, Morgan BP, Todd AJ, Plomp JJ, Willison HJ. Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. Brain. 2004;127:2109\u201323.","journal-title":"Brain"},{"key":"2822_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/glia.20228","volume":"52","author":"SK Halstead","year":"2005","unstructured":"Halstead SK, Morrison I, O\u2019Hanlon GM, Humphreys PD, Goodfellow JA, Plomp JJ, Willison HJ. Anti-disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions. Glia. 2005;52:177\u201389.","journal-title":"Glia"},{"key":"2822_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0165-5728(95)00006-N","volume":"58","author":"FJ Vriesendorp","year":"1995","unstructured":"Vriesendorp FJ, Flynn RE, Pappolla MA, Koski CL. Complement depletion affects demyelination and inflammation in experimental allergic neuritis. J Neuroimmunol. 1995;58:157\u201365.","journal-title":"J Neuroimmunol"},{"key":"2822_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0006-8993(87)90572-5","volume":"419","author":"TE Feasby","year":"1987","unstructured":"Feasby TE, Gilbert JJ, Hahn AF, Neilson M. Complement depletion suppresses Lewis rat experimental allergic neuritis. Brain Res. 1987;419:97\u2013103.","journal-title":"Brain Res"},{"key":"2822_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1177\/1073858403252229","volume":"9","author":"DS Auld","year":"2003","unstructured":"Auld DS, Robitaille R. Perisynaptic Schwann cells at the neuromuscular junction: nerve- and activity-dependent contributions to synaptic efficacy, plasticity, and reinnervation. Neuroscientist. 2003;9:144\u201357.","journal-title":"Neuroscientist"},{"key":"2822_CR36","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain\u2013Barr\u00e9 syndrome. Lancet. 2005;366:1653\u201366.","journal-title":"Lancet"},{"key":"2822_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1529-8027.2009.00243.x","volume":"14","author":"K Kuitwaard","year":"2009","unstructured":"Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA. Recurrences, vaccinations and long-term symptoms in GBS and CIDP. J Peripher Nerv Syst. 2009;14:310\u20135.","journal-title":"J Peripher Nerv Syst"},{"key":"2822_CR38","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1212\/WNL.0b013e3181f88345","volume":"75","author":"L Ruts","year":"2010","unstructured":"Ruts L, Drenthen J, Jongen JL, Hop WC, Visser GH, Jacobs BC, van Doorn PA. Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology. 2010;75:1439\u201347.","journal-title":"Neurology"},{"key":"2822_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","volume":"15","author":"SE Leonhard","year":"2019","unstructured":"Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, et al. Diagnosis and management of Guillain\u2013Barr\u00e9 syndrome in ten steps. Nat Rev Neurol. 2019;15:671\u201383.","journal-title":"Nat Rev Neurol"},{"key":"2822_CR40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain\u2013Barr\u00e9 syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469\u201382.","journal-title":"Nat Rev Neurol"},{"key":"2822_CR41","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1212\/WNL.0000000000013139","volume":"98","author":"AY Doets","year":"2022","unstructured":"Doets AY, Lingsma HF, Walgaard C, Islam B, Papri N, Davidson A, Yamagishi Y, Kusunoki S, Dimachkie MM, Waheed W, et al. Predicting outcome in Guillain\u2013Barr\u00e9 syndrome: international validation of the modified erasmus GBS outcome score. Neurology. 2022;98:e518\u201332.","journal-title":"Neurology"},{"key":"2822_CR42","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1111\/ene.15500","volume":"29","author":"J Kalita","year":"2022","unstructured":"Kalita J, Misra UK, Chaudhary SK, Das M, Mishra A, Ranjan A, Kumar M. Outcome of Guillain\u2013Barr\u00e9 syndrome following intravenous immunoglobulin compared to natural course. Eur J Neurol. 2022;29:3071\u201380.","journal-title":"Eur J Neurol"},{"key":"2822_CR43","doi-asserted-by":"publisher","first-page":"175628642211371","DOI":"10.1177\/17562864221137129","volume":"16","author":"F Kohle","year":"2023","unstructured":"Kohle F, Dalakas MC, Lehmann HC. Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy? Ther Adv Neurol Disord. 2023;16:17562864221137128.","journal-title":"Ther Adv Neurol Disord"},{"key":"2822_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/cm.10176","volume":"58","author":"SA Haque","year":"2004","unstructured":"Haque SA, Hasaka TP, Brooks AD, Lobanov PV, Baas PW. Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured postmitotic neurons. Cell Motil Cytoskeleton. 2004;58:10\u20136.","journal-title":"Cell Motil Cytoskeleton"},{"key":"2822_CR45","doi-asserted-by":"publisher","first-page":"e2108046119","DOI":"10.1073\/pnas.2108046119","volume":"119","author":"A Ogren","year":"2022","unstructured":"Ogren A, Parmar S, Mukherjee S, Gonzalez SJ, Plooster M, McClellan M, Mannava AG, Davidson E, Davis TN, Gardner MK. Kinesin-14 motors participate in a force balance at microtubule plus-ends to regulate dynamic instability. Proc Natl Acad Sci USA. 2022;119:e2108046119.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 24","key":"2822_CR46","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1242\/jcs.113.24.4379","volume":"113","author":"AW Hunter","year":"2000","unstructured":"Hunter AW, Wordeman L. How motor proteins influence microtubule polymerization dynamics. J Cell Sci. 2000;113(Pt 24):4379\u201389.","journal-title":"J Cell Sci"},{"key":"2822_CR47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/bs.pmbts.2014.12.002","volume":"131","author":"JC Fehrenbacher","year":"2015","unstructured":"Fehrenbacher JC. Chemotherapy-induced peripheral neuropathy. Prog Mol Biol Transl Sci. 2015;131:471\u2013508.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2822_CR48","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1091\/mbc.e14-08-1313","volume":"26","author":"OI Kahn","year":"2015","unstructured":"Kahn OI, Sharma V, Gonz\u00e1lez-Billault C, Baas PW. Effects of kinesin-5 inhibition on dendritic architecture and microtubule organization. Mol Biol Cell. 2015;26:66\u201377.","journal-title":"Mol Biol Cell"},{"key":"2822_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13041-018-0422-3","volume":"12","author":"K Yokota","year":"2019","unstructured":"Yokota K, Kubota K, Kobayakawa K, Saito T, Hara M, Kijima K, Maeda T, Katoh H, Ohkawa Y, Nakashima Y, Okada S. Pathological changes of distal motor neurons after complete spinal cord injury. Mol Brain. 2019;12:4.","journal-title":"Mol Brain"},{"key":"2822_CR50","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/1545968310368534","volume":"24","author":"H Van De Meent","year":"2010","unstructured":"Van De Meent H, Hosman AJ, Hendriks J, Zwarts M, Schubert M. Severe degeneration of peripheral motor axons after spinal cord injury: a European multicenter study in 345 patients. Neurorehabil Neural Repair. 2010;24:657\u201365.","journal-title":"Neurorehabil Neural Repair"},{"key":"2822_CR51","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.expneurol.2004.01.026","volume":"187","author":"G Conti","year":"2004","unstructured":"Conti G, Rostami A, Scarpini E, Baron P, Galimberti D, Bresolin N, Contri M, Palumbo C, De Pol A. Inducible nitric oxide synthase (iNOS) in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. Exp Neurol. 2004;187:350\u20138.","journal-title":"Exp Neurol"},{"key":"2822_CR52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF00310924","volume":"82","author":"AF Hahn","year":"1991","unstructured":"Hahn AF, Feasby TE, Wilkie L, Lovgren D. P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration. Acta Neuropathol. 1991;82:60\u20135.","journal-title":"Acta Neuropathol"},{"key":"2822_CR53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ncpneuro0262","volume":"2","author":"A H\u00f6ke","year":"2006","unstructured":"H\u00f6ke A. Mechanisms of disease: what factors limit the success of peripheral nerve regeneration in humans? Nat Clin Pract Neurol. 2006;2:448\u201354.","journal-title":"Nat Clin Pract Neurol"},{"key":"2822_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.expneurol.2009.05.038","volume":"223","author":"D Muir","year":"2010","unstructured":"Muir D. The potentiation of peripheral nerve sheaths in regeneration and repair. Exp Neurol. 2010;223:102\u201311.","journal-title":"Exp Neurol"},{"key":"2822_CR55","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-018-1259-5","volume":"15","author":"AK Mausberg","year":"2018","unstructured":"Mausberg AK, Szepanowski F, Odoardi F, Fl\u00fcgel A, Kleinschnitz C, Stettner M, Kieseier BC. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis. J Neuroinflammation. 2018;15:217.","journal-title":"J Neuroinflammation"},{"key":"2822_CR56","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ana.410230403","volume":"23","author":"K Heininger","year":"1988","unstructured":"Heininger K, Sch\u00e4fer B, Hartung H-P, Fierz W, Linington C, Toyka KV. The role of macrophages in experimental autoimmune neuritis induced by a P2-Specific T-Cell line. Ann Neurol. 1988;23:326\u201331.","journal-title":"Ann Neurol"},{"key":"2822_CR57","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1177\/0192623319838993","volume":"47","author":"E Tomikawa","year":"2019","unstructured":"Tomikawa E, Mutsuga M, Hara K, Kaneko C, Togashi Y, Miyamoto Y. Time course of axon and myelin degeneration in peripheral nerves in experimental autoimmune neuritis rats. Toxicol Pathol. 2019;47:542\u201352.","journal-title":"Toxicol Pathol"},{"key":"2822_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2020.08.020","volume":"91","author":"P Asthana","year":"2021","unstructured":"Asthana P, Zhang G, Sheikh KA, Him Eddie Ma C. Heat shock protein is a key therapeutic target for nerve repair in autoimmune peripheral neuropathy and severe peripheral nerve injury. Brain Behav Immun. 2021;91:48\u201364.","journal-title":"Brain Behav Immun"},{"key":"2822_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027067","volume":"6","author":"G Zhang","year":"2011","unstructured":"Zhang G, Lehmann HC, Bogdanova N, Gao T, Zhang J, Sheikh KA. Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy. PLoS ONE. 2011;6: e27067.","journal-title":"PLoS ONE"},{"key":"2822_CR60","doi-asserted-by":"publisher","first-page":"facb238","DOI":"10.1093\/braincomms\/fcab238","volume":"3","author":"R Klimas","year":"2021","unstructured":"Klimas R, Sgodzai M, Motte J, Mohamad N, Renk P, Blusch A, Gr\u00fcter T, Pedreiturria X, Gobrecht P, Fischer D, et al. Dose-dependent immunomodulatory effects of bortezomib in experimental autoimmune neuritis. Brain Commun. 2021;3:facb238.","journal-title":"Brain Commun."},{"key":"2822_CR61","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1007\/s00415-020-10034-y","volume":"268","author":"J Berciano","year":"2021","unstructured":"Berciano J. Axonal degeneration in Guillain\u2013Barr\u00e9 syndrome: a reappraisal. J Neurol. 2021;268:3728\u201343.","journal-title":"J Neurol"},{"key":"2822_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/cm.20057","volume":"60","author":"SY Yoon","year":"2005","unstructured":"Yoon SY, Choi JE, Huh JW, Hwang O, Lee HS, Hong HN, Kim D. Monastrol, a selective inhibitor of the mitotic kinesin Eg5, induces a distinctive growth profile of dendrites and axons in primary cortical neuron cultures. Cell Motil Cytoskeleton. 2005;60:181\u201390.","journal-title":"Cell Motil Cytoskeleton"},{"key":"2822_CR63","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1113\/JP270874","volume":"594","author":"KR Jessen","year":"2016","unstructured":"Jessen KR, Mirsky R. The repair Schwann cell and its function in regenerating nerves. J Physiol. 2016;594:3521\u201331.","journal-title":"J Physiol"},{"key":"2822_CR64","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1038\/s41467-020-18642-y","volume":"11","author":"O Avraham","year":"2020","unstructured":"Avraham O, Deng P-Y, Jones S, Kuruvilla R, Semenkovich CF, Klyachko VA, Cavalli V. Satellite glial cells promote regenerative growth in sensory neurons. Nat Commun. 2020;11:4891.","journal-title":"Nat Commun"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-023-02822-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-023-02822-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T17:02:50Z","timestamp":1686330170000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-023-02822-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1186\/s12974-023-02822-w","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"18 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were performed according to the guidelines of the European Union Council (86\/609\/EU) and approved by the Local Animal Protection Committee (North-Rhine-Westphalia, Germany authorities for animal experimentation, TV-A 81\u201302.04.2019-A453).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GRF received royalties from Springer, Thieme and Hogrefe. He declared speaker honoraria from Bayer, Desitin, Ergo DKV, Forum f\u00fcr medizinische Fortbildung (FomF) GmbH, GSK, Medica Academy Messe D\u00fcsseldorf, Medicbrain Healthcare, Novartis, Pfizer, and Sport\u00e4rztebund NRW. HCL received honoraria for speaking and advisory board engagement or academic research support by Akcea, Alnylam, Biogen, Celgene, CSL Behring, Grifols, Gruenenthal, LFB Pharma, Takeda and UCB. The other authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}